DexCom (NASDAQ:DXCM) Given New $147.00 Price Target at Raymo

DexCom (NASDAQ:DXCM – Get Free Report) had its price target lifted by stock analysts at Raymond James from $131.00 to $147.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ target price suggests a potential upside of 22.45% from the company’s […]

Related Keywords

United States , Stifel Nicolaus , Raymond James , Leerink Partnrs , Stevenr Altman , Steven Robert Pacelli , Raymond Jame , Harbour Investments Inc , Dexcom Inc , Valley National Advisers Inc , Thompson Siegel Walmsley , Atlas Capital Advisors , Wells Fargo Company , Dexcom Company Profile , Securities Inc , Get Free Report , Com Stock Down , Director Steven , Director Steven Robert Pacelli , Capital Advisors , Valley National Advisers , National Advisers , Dexcom Share , Dexcom Real Time , Dexcom Daily , Dexcom , Nasdaq Dxcm , Dxcm , Medical , 25213110 , Boost Price Target ,